Cargando…
Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer
BACKGROUND: Prostate cancer (PCa) is the second most common cause of cancer-related deaths in American men. Even though increasing evidence has disclosed the competitive endogenous RNA (ceRNA) regulatory networks among cancers, the complexity and behavior characteristics of the ceRNA network in PCa...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043306/ https://www.ncbi.nlm.nih.gov/pubmed/36998469 http://dx.doi.org/10.3389/fonc.2023.1048521 |
_version_ | 1784913116384985088 |
---|---|
author | Yang, Guo Chen, Xiong Quan, Zhen Liu, Miao Guo, Yuan Tang, Yangbin Peng, Lang Wang, Leilei Wu, Yingying Wu, Xiaohou Liu, Jiayu Zheng, Yongbo |
author_facet | Yang, Guo Chen, Xiong Quan, Zhen Liu, Miao Guo, Yuan Tang, Yangbin Peng, Lang Wang, Leilei Wu, Yingying Wu, Xiaohou Liu, Jiayu Zheng, Yongbo |
author_sort | Yang, Guo |
collection | PubMed |
description | BACKGROUND: Prostate cancer (PCa) is the second most common cause of cancer-related deaths in American men. Even though increasing evidence has disclosed the competitive endogenous RNA (ceRNA) regulatory networks among cancers, the complexity and behavior characteristics of the ceRNA network in PCa remain unclear. Our study aimed to investigate the forkhead box A1 (FOXA1)-related ceRNA regulatory network and ascertain potential prognostic markers associated with PCa. METHODS: RNA sequence profiles downloaded from The Cancer Genome Atlas (TCGA) were analyzed to recognize differentially expressed genes (DEGs) derived from tumor and non-tumor adjacent samples as well as FOXA1(low) and FOXA1(high) tumor samples. The enrichment analysis was conducted for the dysregulated mRNAs. The network for the differentially expressed long non-coding RNA (lncRNA)-associated ceRNAs was then established. Survival analysis and univariate Cox regression analysis were executed to determine independent prognostic RNAs associated with PCa. The correlation between DUSP2 and immune cell infiltration level was analyzed. Tissue and blood samples were collected to verify our network. Molecular experiments were performed to explore whether DUSP2 is involved in the development of PCa. RESULTS: A ceRNA network related to FOXA1 was constructed and comprised 18 lncRNAs, 5 miRNAs, and 44 mRNAs. The MAGI2-AS3~has-mir-106a/has-mir-204~DUSP2 ceRNA regulatory network relevant to the prognosis of PCa was obtained by analysis. We markedly distinguished the MAGI2-AS3/DUSP2 axis in the ceRNA. It will most likely become a clinical prognostic model and impact the changes in the tumor immune microenvironment of PCa. The abnormal MAGI2-AS3 expression level from the patients’ blood manifested that it would be a novel potential diagnostic biomarker for PCa. Moreover, down-expressed DUSP2 suppressed the proliferation and migration of PCa cells. CONCLUSIONS: Our findings provide pivotal clues to understanding the role of the FOXA1-concerned ceRNA network in PCa. Simultaneously, this MAGI2-AS3/DUSP2 axis might be a new significant prognostic factor associated with the diagnosis and prognosis of PCa. |
format | Online Article Text |
id | pubmed-10043306 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100433062023-03-29 Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer Yang, Guo Chen, Xiong Quan, Zhen Liu, Miao Guo, Yuan Tang, Yangbin Peng, Lang Wang, Leilei Wu, Yingying Wu, Xiaohou Liu, Jiayu Zheng, Yongbo Front Oncol Oncology BACKGROUND: Prostate cancer (PCa) is the second most common cause of cancer-related deaths in American men. Even though increasing evidence has disclosed the competitive endogenous RNA (ceRNA) regulatory networks among cancers, the complexity and behavior characteristics of the ceRNA network in PCa remain unclear. Our study aimed to investigate the forkhead box A1 (FOXA1)-related ceRNA regulatory network and ascertain potential prognostic markers associated with PCa. METHODS: RNA sequence profiles downloaded from The Cancer Genome Atlas (TCGA) were analyzed to recognize differentially expressed genes (DEGs) derived from tumor and non-tumor adjacent samples as well as FOXA1(low) and FOXA1(high) tumor samples. The enrichment analysis was conducted for the dysregulated mRNAs. The network for the differentially expressed long non-coding RNA (lncRNA)-associated ceRNAs was then established. Survival analysis and univariate Cox regression analysis were executed to determine independent prognostic RNAs associated with PCa. The correlation between DUSP2 and immune cell infiltration level was analyzed. Tissue and blood samples were collected to verify our network. Molecular experiments were performed to explore whether DUSP2 is involved in the development of PCa. RESULTS: A ceRNA network related to FOXA1 was constructed and comprised 18 lncRNAs, 5 miRNAs, and 44 mRNAs. The MAGI2-AS3~has-mir-106a/has-mir-204~DUSP2 ceRNA regulatory network relevant to the prognosis of PCa was obtained by analysis. We markedly distinguished the MAGI2-AS3/DUSP2 axis in the ceRNA. It will most likely become a clinical prognostic model and impact the changes in the tumor immune microenvironment of PCa. The abnormal MAGI2-AS3 expression level from the patients’ blood manifested that it would be a novel potential diagnostic biomarker for PCa. Moreover, down-expressed DUSP2 suppressed the proliferation and migration of PCa cells. CONCLUSIONS: Our findings provide pivotal clues to understanding the role of the FOXA1-concerned ceRNA network in PCa. Simultaneously, this MAGI2-AS3/DUSP2 axis might be a new significant prognostic factor associated with the diagnosis and prognosis of PCa. Frontiers Media S.A. 2023-03-14 /pmc/articles/PMC10043306/ /pubmed/36998469 http://dx.doi.org/10.3389/fonc.2023.1048521 Text en Copyright © 2023 Yang, Chen, Quan, Liu, Guo, Tang, Peng, Wang, Wu, Wu, Liu and Zheng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Yang, Guo Chen, Xiong Quan, Zhen Liu, Miao Guo, Yuan Tang, Yangbin Peng, Lang Wang, Leilei Wu, Yingying Wu, Xiaohou Liu, Jiayu Zheng, Yongbo Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer |
title | Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer |
title_full | Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer |
title_fullStr | Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer |
title_full_unstemmed | Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer |
title_short | Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer |
title_sort | comprehensive analysis of the foxa1-related cerna network and identification of the magi2-as3/dusp2 axis as a prognostic biomarker in prostate cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043306/ https://www.ncbi.nlm.nih.gov/pubmed/36998469 http://dx.doi.org/10.3389/fonc.2023.1048521 |
work_keys_str_mv | AT yangguo comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer AT chenxiong comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer AT quanzhen comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer AT liumiao comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer AT guoyuan comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer AT tangyangbin comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer AT penglang comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer AT wangleilei comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer AT wuyingying comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer AT wuxiaohou comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer AT liujiayu comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer AT zhengyongbo comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer |